In a filing, Achieve Life Sciences Inc. revealed its CEO Bencich John acquired Company’s shares for reported $27500.0 on May 30. In the deal valued at $5.50 per share,5,000 shares were bought. As a result of this transaction, Bencich John now holds 66,730 shares worth roughly $ 0.35 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Maxim Group reiterated its Achieve Life Sciences Inc. [ACHV] rating to a Buy in a research note published on Friday, May 10, 2023; the price target was $20. PT values the company’s stock at a premium of 74.1 to its Friday closing price.
Price Performance Review of ACHV
On Friday, Achieve Life Sciences Inc. [NASDAQ:ACHV] saw its stock jump 4.44% to $5.18. On the same session, the stock had its day’s lowest price of $4.88, but rose to a high of $5.36. Over the last five days, the stock has gained 11.64%. Achieve Life Sciences Inc. shares have risen nearly 111.43% since the year began. Nevertheless, the stocks have risen 13.60% over the past one year. While a 52-week high of $10.30 was reached on 05/11/23, a 52-week low of $2.00 was recorded on 01/04/23. SMA at 50 days reached $5.24, while 200 days put it at $5.21. A total of 58764.0 shares were traded, compared to the trading of 46100.0 shares in the previous session.
Levels Of Support And Resistance For ACHV Stock
The 24-hour chart illustrates a support level at 4.92, which if violated will result in even more drops to 4.66. On the upside, there is a resistance level at 5.40. A further resistance level may holdings at 5.62. The Relative Strength Index (RSI) on the 14-day chart is 53.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.78%. Stochastics %K at 59.04% indicates the stock is a holding.
How much short interest is there in Achieve Life Sciences Inc.?
A steep rise in short interest was recorded in Achieve Life Sciences Inc. stocks on Aug 14, 2023, dropping by 79200.0 shares to a total of 0.73 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.81 million shares. There was a decline of -10.87%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 4.15% of the overall stock float, the days-to-cover ratio (short ratio) fell to 17.13.
Achieve Life Sciences Inc. [ACHV] – Who Are The Largest Shareholders?
In filings from Shay Capital LLC, it is revealed that the company now owns 776,600 shares, or roughly 3.69% of the outstanding ACHV shares. In other words, the investor’s shares have risen by 296,600 from its previous 13-F filing of 480000.0. Additionally, The Vanguard Group, Inc. increased 35.83% of its stake after which the total value it holdings stand at $3,190,034, while Francis Capital Management LLC reduced -22.79% of its stake to hold $2.42 million in the firm. At present, B. Riley Wealth Advisors, Inc. is holding 216,216 shares valued at $1.21 million. Geode Capital Management LLC owned 162,288 shares of the company at the time of its most recent 13F filing, worth $0.91 million.
According to FactSet, Achieve Life Sciences Inc.’s share price will average $28.57 in the next year, based on opinions of analysts polled by the firm. This is up nearly 404.03 percent from its previous closing price of $4.96. Analysts expect Achieve Life Sciences Inc. stock to reach the higher price of $56.00, while the lowest price estimate is $19.00. However, 6 analysts have rated ACHV stock as a Buy in their predictions for 2023.